Cancer therapy, redefined

Novel personalized immunotherapy

We are a team specializing in CAR technology, advancing cancer immunotherapy with gene-engineered immune cells. We develop personalized therapies by reprogramming patients’ immune cells to precisely target and eliminate cancer. At the Chair of Cellular Immunotherapy at the University Hospital Würzburg, we identify therapeutically relevant cancer targets and develop novel CAR T cell products using rapid, cost-effective, non-viral manufacturing methods. With extensive clinical trial experience, we translate innovative therapies from research into patient care.

We benefit from a strong network of research institutions and close ties to the biotech industry, including T-CURX, a biotech startup spun out of our chair, and the Fraunhofer Institute for Cell Therapy and Immunology (IZI). The Würzburg branch of Fraunhofer IZI, like our chair, is led by Prof. Michael Hudecek.